ViAqua Therapeutics Overview
Update this profile
Latest Deal Type
Early Stage VC
ViAqua Therapeutics General Information Description
Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics in aquaculture. The company's platform utilizes a proprietary RNAi nanoparticle formulation that triggers a cellular reaction to disable the viral infection and delivers the coated nanoparticles via feed or immersion, enabling aquaculture industries to improve resistance against viral diseases that attack shrimp and other aquaculture species.
Want to dig into this profile?
We’ll help you find what you need
ViAqua Therapeutics Comparisons
Last Financing Details
Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics
g elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
As of 0000
dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
As of 0000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trial
ViAqua Therapeutics Competitors (3)
Last Financing Date/Type
Last Financing Amount
ViroVet Venture Capital-Backed
0000000 Private Debt Financed
000000 0000000 000 Formerly PE-Backed
To view ViAqua Therapeutics’s complete competitors history, request access »